Atlas Trials

Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy

Clinical trial NCT05679336 · UNKNOWN

Trial details

NCT number
NCT05679336
Sponsor
St. Petersburg State Pavlov Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Membranous Nephropathy - PLA2R Induced
Start date
2018-05-01
Primary completion
2024-08-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.